Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
168
NCT05079425
A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 1, 2021
Completion: Nov 1, 2022
NCT06104839
Safety and Efficacy of Oral NXC-736 in Adult Participants with Moderate and Severe Alopecia Areata
Phase: Phase 2
Start: Sep 1, 2024
Completion: Jun 30, 2025